These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21917968)

  • 41. Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.
    Vogt A; Scull MA; Friling T; Horwitz JA; Donovan BM; Dorner M; Gerold G; Labitt RN; Rice CM; Ploss A
    Virology; 2013 Sep; 444(1-2):1-11. PubMed ID: 23777661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.
    Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S
    Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
    Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
    Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of the 5' Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication.
    Tanaka T; Otoguro T; Yamashita A; Kasai H; Fukuhara T; Matsuura Y; Moriishi K
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-122, small RNA annealing and sequence mutations alter the predicted structure of the Hepatitis C virus 5' UTR RNA to stabilize and promote viral RNA accumulation.
    Amador-Cañizares Y; Panigrahi M; Huys A; Kunden RD; Adams HM; Schinold MJ; Wilson JA
    Nucleic Acids Res; 2018 Oct; 46(18):9776-9792. PubMed ID: 30053137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122.
    Lin LT; Noyce RS; Pham TN; Wilson JA; Sisson GR; Michalak TI; Mossman KL; Richardson CD
    J Virol; 2010 Sep; 84(18):9170-80. PubMed ID: 20592082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A preliminary analysis of hepatitis C virus in pancreatic islet cells.
    Blackard JT; Kong L; Lombardi A; Homann D; Hammerstad SS; Tomer Y
    Virol J; 2017 Dec; 14(1):237. PubMed ID: 29258547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supporting Role for GTPase Rab27a in Hepatitis C Virus RNA Replication through a Novel miR-122-Mediated Effect.
    Chen TC; Hsieh CH; Sarnow P
    PLoS Pathog; 2015 Aug; 11(8):e1005116. PubMed ID: 26305877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus infection of cholangiocarcinoma cell lines.
    Fletcher NF; Humphreys E; Jennings E; Osburn W; Lissauer S; Wilson GK; van IJzendoorn SCD; Baumert TF; Balfe P; Afford S; McKeating JA
    J Gen Virol; 2015 Jun; 96(Pt 6):1380-1388. PubMed ID: 25701818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.
    Bhanja Chowdhury J; Shrivastava S; Steele R; Di Bisceglie AM; Ray R; Ray RB
    J Virol; 2012 Sep; 86(18):10221-5. PubMed ID: 22787204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of microRNA-199a-5p reduces the replication of HCV via regulating the pro-survival pathway.
    Wang H; Gao H; Duan S; Song X
    Virus Res; 2015 Oct; 208():7-12. PubMed ID: 26027911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel function of CD81 in controlling hepatitis C virus replication.
    Zhang YY; Zhang BH; Ishii K; Liang TJ
    J Virol; 2010 Apr; 84(7):3396-407. PubMed ID: 20089661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.
    Li Y; Yamane D; Lemon SM
    J Virol; 2015 May; 89(9):4857-65. PubMed ID: 25673723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beyond sites 1 and 2, miR-122 target sites in the HCV genome have negligible contributions to HCV RNA accumulation in cell culture.
    Bernier A; Sagan SM
    J Gen Virol; 2019 Feb; 100(2):217-226. PubMed ID: 30652963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
    Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
    J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human immunodeficiency virus type 1 Vpr increases hepatitis C virus RNA replication in cell culture.
    Deng A; Chen C; Ishizaka Y; Chen X; Sun B; Yang R
    Virus Res; 2014 May; 184():93-102. PubMed ID: 24589706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis.
    Banaudha K; Orenstein JM; Korolnek T; St Laurent GC; Wakita T; Kumar A
    Hepatology; 2010 Jun; 51(6):1922-32. PubMed ID: 20512986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a
    Tong Y; Chi X; Yang W; Zhong J
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation.
    Puig-Basagoiti F; Fukuhara T; Tamura T; Ono C; Uemura K; Kawachi Y; Yamamoto S; Mori H; Kurihara T; Okamoto T; Aizaki H; Matsuura Y
    J Virol; 2016 Oct; 90(19):8464-77. PubMed ID: 27440892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.